127 related articles for article (PubMed ID: 26861605)
21. Treatment and Outcome of Patients with Stage IS Testicular Cancer: A Retrospective Study from the Spanish Germ Cell Cancer Group.
Aparicio J; Sánchez-Muñoz A; Ochenduszko S; Gumà J; Fernández-Aramburo A; García Del Muro X; Quiroga V; Sastre J; Alonso-Gordoa T; Sagastibelza N; Maroto P; Gómez de Liaño A; Vázquez S; Diz P; Durán I; Domenech M; Pinto A; Hernández A; González-Billalabeitia E; Terrasa J
J Urol; 2019 Oct; 202(4):742-747. PubMed ID: 31163007
[TBL] [Abstract][Full Text] [Related]
22. Surveillance after Complete Response to First-Line Chemotherapy in Patients with Metastatic Nonseminomatous Germ Cell Tumor.
King JM; Althouse S; Cary C; Masterson T; Foster RS; Ashkar R; Hanna NH; Einhorn LH; Adra N
J Urol; 2022 Sep; 208(3):641-649. PubMed ID: 35674780
[TBL] [Abstract][Full Text] [Related]
23. Pre-orchiectomy tumor marker levels should not be used for International Germ Cell Consensus Classification (IGCCCG) risk group assignment.
Fankhauser CD; Gerke TA; Roth L; Sander S; Grossmann NC; Kranzbühler B; Eberli D; Sulser T; Beyer J; Hermanns T
J Cancer Res Clin Oncol; 2019 Mar; 145(3):781-785. PubMed ID: 30637464
[TBL] [Abstract][Full Text] [Related]
24. Long-term survival in patients with primary intracranial germ cell tumors treated with surgery, platinum-based chemotherapy, and radiotherapy: a single-institution study.
Shimizu H; Motomura K; Ohka F; Aoki K; Tanahashi K; Hirano M; Chalise L; Nishikawa T; Yamaguchi J; Yoshida J; Natsume A; Wakabayashi T
J Neurosurg; 2020 Oct; ():1-9. PubMed ID: 33007755
[TBL] [Abstract][Full Text] [Related]
25. Site of extranodal metastasis impacts survival in patients with testicular germ cell tumors.
Patel HD; Singla N; Ghandour RA; Freifeld Y; Cheaib JG; Woldu SL; Pierorazio PM; Bagrodia A
Cancer; 2019 Nov; 125(22):3947-3952. PubMed ID: 31355922
[TBL] [Abstract][Full Text] [Related]
26. Histopathology and prognosis of germ cell tumors metastatic to brain: cohort study.
Takami H; Graffeo CS; Perry A; Ohno M; Ishida J; Giannini C; Narita Y; Nakazato Y; Saito N; Nishikawa R; Matsutani M; Ichimura K; Daniels DJ
J Neurooncol; 2021 Aug; 154(1):121-130. PubMed ID: 34272633
[TBL] [Abstract][Full Text] [Related]
27. Outcomes After Multidisciplinary Management of Primary Mediastinal Germ Cell Tumors.
Caso R; Jones GD; Bains MS; Hsu M; Tan KS; Feldman DR; Funt SA; Reuter VE; Bosl GJ; McHugh D; Huang J; Molena D; Amar D; Fischer G; Rusch VW; Jones DR
Ann Surg; 2021 Dec; 274(6):e1099-e1107. PubMed ID: 31977510
[TBL] [Abstract][Full Text] [Related]
28. Primary mediastinal germ cell tumours: real world experience in the low middle income (LMIC) setting.
Joel A; Mathew N; Andugala SS; Daniel S; Gnanamuthu BR; John AO; Georgy JT; Chacko RT; Irodi A; Yadav B; John S; Singh A
Ecancermedicalscience; 2021; 15():1186. PubMed ID: 33777179
[TBL] [Abstract][Full Text] [Related]
29. Body Mass Index and Outcomes in Germ-Cell Tumors.
McGregor BA; Miller RE; O'Donnell E; Albiges LK; Sweeney CJ; Markt SC
Clin Genitourin Cancer; 2019 Aug; 17(4):283-290. PubMed ID: 31129146
[TBL] [Abstract][Full Text] [Related]
30. Primary Mediastinal Germ Cell Tumors (PMGCT): A Real-world Analysis From A Tertiary Cancer Care Center in India.
Sharma A; Reddy R; Pramanik R; Sahoo RK; Kaushal S; Haresh KP; Kumar S; Kumar L; Sharma A; Batra A
Cancer Invest; 2023 May; 41(5):467-473. PubMed ID: 36927242
[TBL] [Abstract][Full Text] [Related]
31. Misuse of tumor marker levels leads to an insufficient International Germ Cell Consensus Classification (IGCCCG) risk group assignment and impaired treatment.
Majewski M; Paffenholz P; Ruf C; Che Y; Seidel C; Heinzelbecker J; Schmelz HU; Matthies C; Albers P; Bokemeyer C; Heidenreich A; Pichler M; Nestler T;
Cancer Med; 2023 Aug; 12(16):16829-16836. PubMed ID: 37392170
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database.
Lauritsen J; Sauvé N; Tryakin A; Jiang DM; Huddart R; Heng DYC; Terbuch A; Winquist E; Chovanec M; Hentrich M; Fankhauser CD; Shamash J; Del Muro XG; Vaughn D; Heidenreich A; Sternberg CN; Sweeney C; Necchi A; Bokemeyer C; Bandak M; Jandari A; Collette L; Gillessen S; Beyer J; Daugaard G
Br J Cancer; 2023 Nov; 129(11):1759-1765. PubMed ID: 37777577
[TBL] [Abstract][Full Text] [Related]
33. Extragonadal Germ Cell Tumors of the Mediastinum and Retroperitoneum: A Surveillance, Epidemiology, and End Results-based Study.
Aguiar Bujanda D; Pérez Cabrera D; Croissier Sánchez L
Am J Clin Oncol; 2022 Dec; 45(12):493-500. PubMed ID: 36394133
[TBL] [Abstract][Full Text] [Related]
34. Treatment outcomes and risk factors of patients with intracranial germ cell tumour with choriocarcinoma element or β-HCG level higher than 500 IU/L.
Feng J; Zhang J; Chen L; Li C; Liu W; Chen H; Qiu X; Li B
J Neurooncol; 2024 Jan; 166(2):331-339. PubMed ID: 38236548
[TBL] [Abstract][Full Text] [Related]
35. Improved survival of poor-risk non-seminomatous germ cell tumor patients: real-world data from a single institute in Japan.
Tanuma K; Kawai K; Nitta S; Shiga M; Kawahara T; Negoro H; Onozawa M; Inoue T; Nishiyama H; Miyazaki J
Jpn J Clin Oncol; 2023 Jan; 53(1):74-79. PubMed ID: 36151048
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors and outcomes of nonseminomatous germ cell tumours of testis-experience from a tertiary cancer centre in India.
Nair LM; Krishna KMJ; Kumar A; Mathews S; Joseph J; James FV
Ecancermedicalscience; 2020; 14():1145. PubMed ID: 33343704
[TBL] [Abstract][Full Text] [Related]
37. Survival Outcomes of Patients With Mediastinal Germ Cell Tumors: Experience of a Cancer Center in South America.
Vallejo-Yepes C; Carvajal-Fierro CA; Brugés-Maya R; Beltrán J; Buitrago R; Beltrán-Jimenez R; Carreño-Dueñas JA
Front Oncol; 2021; 11():758496. PubMed ID: 35047390
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology, Management, and Survival Outcomes of Germ Cell Cancer in Southern Portugal: A Population-Based Study (2008-2012).
Brito M; Ramos M; Silva JP; Câmara G; Mayer A; Miranda A; Coelho JLP; Moreira A; Esteves S
Clin Genitourin Cancer; 2024 Feb; 22(1):e170-e177.e1. PubMed ID: 38061978
[TBL] [Abstract][Full Text] [Related]
39. Assessment of Resectability of Mediastinal Germ Cell Tumor Using Preoperative Computed Tomography.
Kawakubo N; Okubo Y; Yotsukura M; Yoshida Y; Nakagawa K; Yonemori K; Watanabe H; Yatabe Y; Watanabe SI
J Surg Res; 2022 Apr; 272():61-68. PubMed ID: 34936913
[TBL] [Abstract][Full Text] [Related]
40. Delivered relative dose intensity in adolescent and young adult germ cell tumours in England: Assessment of data quality and consistency from clinical trials compared to national cancer registration data.
Hughes NF; Cromie KJ; Feltbower RG; McCabe MG; Stark D
Int J Cancer; 2024 Mar; 154(5):816-829. PubMed ID: 37860893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
